The Endocannabinoid System
Your Body's Master Regulator
The endocannabinoid system (ECS) is a vast molecular signalling network present in virtually every tissue of the human body. First mapped in the early 1990s, it regulates homeostasis across neurological, immune, metabolic, and reproductive systems.
The ECS operates through two primary receptor families — CB1 (concentrated in the central nervous system) and CB2 (distributed throughout peripheral tissues and immune cells) — and the endogenous ligands that activate them: anandamide (AEA) and 2-arachidonoylglycerol (2-AG).
Dysregulation of ECS tone has been implicated in chronic pain, sleep disorders, mood dysregulation, neuroinflammation, metabolic dysfunction, and autoimmune conditions. Restoring balance through precision medicine is MMCO's clinical mandate.
Unlike broad-spectrum interventions, our approach begins with individual receptor profiling, genomic analysis, and biomarker assessment — mapping your unique ECS before designing any protocol.
Our Methodology
Precision. Protocol. Partnership.
Precision Diagnostics
ECS biomarker testing, genomic receptor profiling (CNR1/CNR2 variants), endocannabinoid tone assessment, FAAH and MAGL enzyme activity — your baseline, mapped in molecular detail.
Personalised Protocols
Bespoke cannabinoid formulations calibrated to your receptor profile. Delivery optimisation — oral, sublingual, topical, inhaled — matched to your pharmacokinetics. No off-the-shelf protocols. Ever.
Concierge Access
Direct line to your clinician. Same-day response. Quarterly biomarker reviews. Protocol refinements in real time. Limited patient roster by design — because precision care requires presence.
Evidence-Based. Clinically Rigorous. Molecularly Precise.
Our protocols are grounded in peer-reviewed ECS research.
ECS & Chronic Pain
Research published in peer-reviewed pharmacology journals demonstrates that upregulation of CB1 and CB2 receptor activity significantly modulates nociceptive signalling, offering a precision target for chronic pain management without the dependency risks of traditional opioid pathways.
ECS & Neuroinflammation
Studies across multiple neuroscience journals confirm that endocannabinoid system dysregulation correlates with elevated neuroinflammatory markers in conditions including fibromyalgia, PTSD, and treatment-resistant depression — establishing ECS modulation as a clinically relevant intervention target.
ECS & Metabolic Function
Converging evidence from metabolic medicine research shows that ECS tone directly influences insulin sensitivity, adipogenesis, and appetite regulation — with receptor-specific interventions demonstrating measurable improvements in metabolic biomarkers.
Healthcare as it should be.
Personal. Precise. Unhurried.
- 01
Initial Discovery Call
A 30-minute conversation with your clinician. No forms, no algorithms — just a direct clinical dialogue about your health history, goals, and ECS-related concerns.
- 02
Comprehensive ECS Assessment
Biomarker panel, genomic receptor analysis (CNR1/CNR2), endocannabinoid tone mapping, and a full metabolic and neurological health review.
- 03
Personalised Protocol Design
Your clinician synthesises all data into a bespoke cannabinoid protocol — compound selection, dosing, delivery method, timing — built around your molecular profile.
- 04
Ongoing Monitoring
Real-time access to your clinician. Monthly check-ins. Biomarker tracking. Protocol adjustments as your ECS responds and evolves.
- 05
Adaptive Refinement
Quarterly comprehensive reviews. Protocol refinements based on outcome data. Long-term ECS optimisation — not a one-time prescription.
Patient Outcomes
What our patients experience.
Verified 5-star Google reviews from Medical Marijuana Cards Online patients.
Dr. Lee R. Ferguson, MD, PhD, MBA
Physician Scientist · Integrative Medicine · ECS Specialisation
Two decades of clinical practice in integrative and precision medicine, with sub-specialisation in endocannabinoid system pharmacology.
Your ECS. Your Protocol. Your Outcomes.
Spaces are limited. Concierge care by appointment only.
Online inquiry submission is not yet active. Please contact our office directly.